Our Services
Specialized advisory for medical device companies, PE/VC investors, and healthcare innovators navigating complex European markets.
Commercial Strategy & Go-to-Market Advisory
We help MedTech companies design and execute commercial strategies that drive measurable growth. Whether you are entering a new European market, launching a new product category, or restructuring your go-to-market model, we bring hands-on experience from leading commercial operations at global MedTech companies.
Our approach combines rigorous market analysis with practical execution planning. We assess market dynamics, reimbursement landscapes, competitive positioning, and channel strategies to build actionable plans that deliver results, not just reports.
Who This is For
MedTech companies entering new European markets, launching new product lines, or seeking to accelerate growth in existing markets.
Engagement Format
Project-based (typically 8-12 weeks) or ongoing advisory retainer.
Example Deliverables
- Market sizing and opportunity assessment
- Competitive landscape analysis
- Channel strategy and partner selection
- Pricing and reimbursement strategy
- Go-to-market execution roadmap
- Sales force design and territory planning
M&A Commercial Due Diligence
Private equity funds and strategic buyers need more than financial models when evaluating MedTech targets. Our commercial due diligence goes deep on the questions that determine whether a deal will create value: Is the market growing? Is the competitive position defensible? Can the commercial engine scale?
With direct experience managing P&Ls exceeding EUR 210M and integrating acquisitions valued at over EUR 130M, we bring operator perspective to the deal process. We have sat on both sides of the table and understand what makes MedTech businesses succeed or fail post-acquisition.
Who This is For
PE/VC funds evaluating MedTech targets, strategic acquirers planning bolt-on acquisitions, and portfolio companies preparing for exit.
Engagement Format
Project-based, typically 3-6 weeks aligned to deal timelines.
Example Deliverables
- Commercial due diligence report
- Market and competitive analysis
- Customer and KOL reference checks
- Revenue sustainability assessment
- Commercial value creation plan
- 100-day post-acquisition roadmap
Interim & Fractional Executive Leadership
Leadership transitions, organizational restructuring, and rapid scaling all require experienced hands at the helm. We provide interim and fractional executive leadership for MedTech companies that need senior commercial expertise without the time or commitment of a permanent hire.
Our interim engagements are not about keeping the seat warm. We drive change, build capability, and deliver results during the engagement period. Every interim assignment comes with a clear mandate, measurable objectives, and a structured handover plan.
Who This is For
MedTech companies in leadership transition, PE portfolio companies post-acquisition, and organizations scaling into new markets.
Engagement Format
Interim (3-12 months, 3-5 days/week) or fractional (ongoing, 1-2 days/week).
Example Deliverables
- Interim CCO, Country Manager, or VP Commercial role
- Organizational assessment and restructuring
- Team development and capability building
- Commercial process optimization
- KPI framework and performance management
- Structured handover to permanent leadership
Digital Health & AI Commercialization Advisory
The technology is rarely the bottleneck in digital health. Commercialization is. Regulatory pathways, reimbursement models, buyer personas, and procurement processes in healthcare are fundamentally different from traditional software or consumer tech markets.
We help digital health companies and MedTech innovators navigate the commercialization challenge. From defining the right business model to building clinical evidence strategies and engaging with payers, we bridge the gap between innovation and market adoption.
Who This is For
Digital health startups and scale-ups, MedTech companies launching connected devices, and investors evaluating digital health opportunities.
Engagement Format
Project-based (8-12 weeks) or ongoing advisory retainer.
Example Deliverables
- Commercialization strategy and business model design
- Payer and reimbursement pathway analysis
- Clinical evidence and health economics planning
- Regulatory strategy alignment (MDR/IVDR)
- Buyer journey and persona mapping
- Pilot and scaling framework
Regulatory & Market Access Strategy
The European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have fundamentally changed the competitive landscape in European MedTech. Companies that treat regulatory compliance as purely a technical exercise miss the strategic implications for portfolio management, market access, and commercial planning.
We help MedTech companies understand and respond to the commercial impact of regulatory change. Our focus is on aligning regulatory strategy with commercial objectives to protect market position and capture new opportunities.
Who This is For
MedTech companies navigating MDR/IVDR transition, distributors rationalizing product portfolios, and manufacturers planning European market entry.
Engagement Format
Project-based (6-10 weeks) or advisory retainer.
Example Deliverables
- MDR/IVDR commercial impact assessment
- Portfolio rationalization strategy
- Market access and reimbursement planning
- Regulatory-commercial alignment roadmap
- Competitive positioning analysis post-MDR
- Distributor and channel strategy review
PE/VC MedTech Investment Support
MedTech investing requires deep sector knowledge. We work with PE/VC funds as a specialized resource throughout the investment lifecycle: from pre-deal screening and commercial due diligence, through portfolio company support and value creation, to exit preparation.
Our value is in translating operator experience into investor-relevant insights. We help funds ask the right questions, validate commercial assumptions, and build actionable value creation plans that drive returns.
Who This is For
PE/VC funds with MedTech portfolios or deal pipelines, family offices evaluating healthcare investments, and corporate venture arms.
Engagement Format
Retainer (ongoing sector advisory) or project-based (aligned to deal timelines).
Example Deliverables
- Deal screening and sector mapping
- Commercial due diligence
- Value creation planning and execution
- Portfolio company board advisory
- Exit readiness assessment
- Industry expert introductions
Expert Network & Advisory Board Services
Sometimes you need a trusted perspective rather than a full engagement. We provide expert consultations for investors, consultancies, and corporations seeking senior MedTech insight on specific questions: market dynamics, competitive positioning, deal evaluation, or strategic direction.
We also design and facilitate advisory boards for MedTech companies seeking structured external guidance on commercial strategy, market entry, or portfolio decisions.
Who This is For
Expert networks (GLG, AlphaSights, Guidepoint), management consultancies, investors conducting market studies, and MedTech companies building advisory boards.
Engagement Format
Hourly consultations or structured advisory board programs.
Example Deliverables
- Expert consultation calls
- Advisory board design and facilitation
- Strategic workshop facilitation
- Market landscape briefings
- Competitive intelligence sessions
Need a tailored approach?
Every engagement is designed around your specific challenge. Let us discuss how we can help.
Start a Conversation